The Effectiveness of Miorelaxant "Muscomed" In Patients with Muscular-Tonic Syndrome Caused by Osteochondrosis of The Spine
DOI:
https://doi.org/10.61788/njn.spec.17.12Keywords:
muscular-tonic syndrome, spinal osteochondrosis, vertebrogenic pain syndrome, muscle relaxants, Muscomed, treatmentAbstract
A clinical study of the efficacy and tolerability of the drug “Muscomed” in the complex treatment of 60 patients with muscular-tonic syndromes caused by osteochondrosis of various parts of the spine was carried out. In the control group (n = 30), conventional drug therapy (nonsteroidal anti-inflammatory drugs, therapy with vitamins, physiotherapy, massage) was performed, as well as intramuscular injection of muscle relaxant “Muscomed” in a dosage of 2 ml for 6 days. In the main group (n = 30), along with the aforementioned complex of treatment for patients, an external application of 0.25% cream of “Muscomed” was proposed for the entire treatment period. As a result of the treatment, the effectiveness and tolerability of “Muscomed” was more pronounced in patients in the main group.
References
Хабиров Ф.А. Клиническая неврология позвоночника. Казань, 2003, 470 с.
Попелянский Я.Ю. Болезни периферической нервной системы // Руководство. М.: Медицина, 1989, 463 с.
Камчатнов П.Р., Чугунов А.В., Умарова Х.Я., Воловец С.А. Терапия острого вертеброгенного болевого синдрома // Consilium medicum. - 2005. - Т. 7. - С.125-132.
Федотова А.В., Вознесенская T.Г. Баклофен при лечении болей в спине, мышечно-тонических и миофасциальных болевых синдромов // Лечение нервных болезней. - 2004. - № 2 (14). - С.19-22.
Кукушкин М.Л., Табеева Г.Р., Подчуфарова Е.В. Болевой синдром: патофизиология, клиника, лечение // Клинические рекомендации. Под ред. акад. РАМН Н.Н. Яхно. - М.: ИМА-ПРЕСС, 2011. – 72 с.
Широков В.А. Эффективность локальной инъекционной терапии препаратом мидокалм миофасциальных болевых синдромов шейно-плечевой области // Журнал неврологии и психиатрии им. С.С. Корсакова. - 2009. - Т.109, № 6. - С.78-80.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



